Follow The Filings

SYRESpyre Therapeutics Inc.

Q3 2024 13F holders among managers we track Latest ownership dossier

Ticker
SYRE
Type
Equity
Class
COM NEW
Total reported value (long equity)
Manager Report date Value Shares